OnKure Therapeutics
OKUR | NASDAQ
$2.75
+$0.12 (+4.56%)
At close: Nov 16, 2026, 4:00 PM ET
$2.75
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:10 PM ET
+4.56%
(1D)No price chart data available for 1D timeframe.
Rating
24.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #936/1021 (Top 92%)
Key Statistics
Market Data
Market Cap $137.3M
1D Range
2.50 2.81
52W Range
2.10 5.27
Valuation (TTM)
PE -0.99
PB 0.87
EV/EBITDA 0.40
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $14.00
Cash Flow
FCF Yield -34.9%
SBC Adj. FCF Yield -43.9%
SBC Impact -25.7%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -33.4% |
47.4%
FCF 3Y | 5Y -34.6% |
-12.4%
Returns
ROA -37.0%
ROE -43.4%
ROIC -41.6%
Financial Health
Net Cash
$163.31M
Current Ratio 18.84
Interest Coverage -10,998.33
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A ...
Sector Healthcare
Industry Biotechnology
Employees 45
IPO Date Apr 8, 2021
Website onkuretherapeutics.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$14.00
Upside
+409.09%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove OKUR